Cargando…
Radiomics Signature to Predict Prognosis in Early-Stage Lung Adenocarcinoma (≤3 cm) Patients with No Lymph Node Metastasis
Objectives: To investigate the predictive ability of radiomics signature to predict the prognosis of early-stage primary lung adenocarcinoma (≤3 cm) with no lymph node metastasis (pathological stage I). Materials and Methods: This study included consecutive patients with lung adenocarcinoma (≤3 cm)...
Autores principales: | Zhang, Li, Lv, Lv, Li, Lin, Wang, Yan-Mei, Zhao, Shuang, Miao, Lei, Gao, Yan-Ning, Li, Meng, Wu, Ning |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406362/ https://www.ncbi.nlm.nih.gov/pubmed/36010257 http://dx.doi.org/10.3390/diagnostics12081907 |
Ejemplares similares
-
Imbalanced Data Correction Based PET/CT Radiomics Model for Predicting Lymph Node Metastasis in Clinical Stage T1 Lung Adenocarcinoma
por: Lv, Jieqin, et al.
Publicado: (2022) -
Radiomics Signature on Computed Tomography Imaging: Association With Lymph Node Metastasis in Patients With Gastric Cancer
por: Jiang, Yuming, et al.
Publicado: (2019) -
Relationship Between Radiomics and Risk of Lymph Node Metastasis in Pancreatic Ductal Adenocarcinoma
por: Bian, Yun, et al.
Publicado: (2019) -
Radiomics nomogram for the preoperative prediction of lymph node metastasis in pancreatic ductal adenocarcinoma
por: Bian, Yun, et al.
Publicado: (2022) -
Identification of critical prognosis signature associated with lymph node metastasis of stomach adenocarcinomas
por: Wang, Xiaohui, et al.
Publicado: (2023)